PTAB Rejects IPR Challenge To Genentech Arthritis Patent
Celltrion Inc. lost a renewed effort to challenge in inter partes review a Genentech Inc. patent on a method of treating rheumatoid arthritis, as the Patent Trial and Appeal Board decided...To view the full article, register now.
Already a subscriber? Click here to view full article